1358/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de B466 - BOSENTANO [32 MG; COMP DISP], B925 - BEDAQUILINA [100 MG; CÁP/COMP], T1818 - TECLISTAMAB [90 MG/ML; 1,7 ML; SO

ID 11290657 · Portal BASE
Price
Base Price
€6,320,496 .00
Effective Price
€5,784 .00 -99.9%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Porto
Bidder Count
1
Winner
JANSSEN - CILAG FARMACÊUTICA LDA
NIF 500189412
Company
Competition
1 bidder recorded
JANSSEN - CILAG FARMACÊUTICA LDA
NIF 500189412
Dates
Publication
18 Mar 2025
Celebration
07 Feb 2025
Contracting Entity
Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.
NIF 506362299
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 70 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
18 Mar 2025
Signing Date
07 Feb 2025
Days Late
39
Rule
A2/A3 late publication: 39 days after signing (threshold: 10)
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
6320496.0
Total effective price
5784.0
Ratio
0.0009
Direction
reduction
Rule
A9 price reduction: ratio 0.0009 outside [0.5, 1.5]
Detected 2026-03-06